These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 33706723)
1. Socio-economic drivers of drug-resistant tuberculosis in Africa: a scoping review. Cannon LL; Oladimeji KE; Goon DT BMC Public Health; 2021 Mar; 21(1):488. PubMed ID: 33706723 [TBL] [Abstract][Full Text] [Related]
2. Psycho-Socio-Economic Issues Challenging Multidrug Resistant Tuberculosis Patients: A Systematic Review. Thomas BE; Shanmugam P; Malaisamy M; Ovung S; Suresh C; Subbaraman R; Adinarayanan S; Nagarajan K PLoS One; 2016; 11(1):e0147397. PubMed ID: 26807933 [TBL] [Abstract][Full Text] [Related]
3. High use of private providers for first healthcare seeking by drug-resistant tuberculosis patients: a cross-sectional study in Yangon, Myanmar. Sidharta SD; Yin JD; Yoong JS; Khan MS BMC Health Serv Res; 2018 Apr; 18(1):276. PubMed ID: 29642905 [TBL] [Abstract][Full Text] [Related]
4. Tuberculosis active case-finding interventions and approaches for prisoners in sub-Saharan Africa: a systematic scoping review. Kuupiel D; Vezi P; Bawontuo V; Osei E; Mashamba-Thompson TP BMC Infect Dis; 2020 Aug; 20(1):570. PubMed ID: 32758165 [TBL] [Abstract][Full Text] [Related]
5. Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa--a systematic review. Barter DM; Agboola SO; Murray MB; Bärnighausen T BMC Public Health; 2012 Nov; 12():980. PubMed ID: 23150901 [TBL] [Abstract][Full Text] [Related]
6. Case-Finding Strategies for Drug-Resistant Tuberculosis: Protocol for a Scoping Review. Van Wyk SS; Nliwasa M; Seddon JA; Hoddinott G; Viljoen L; Nepolo E; Günther G; Ruswa N; Lin HH; Niemann S; Gandhi NR; Shah NS; Claassens M JMIR Res Protoc; 2022 Dec; 11(12):e40009. PubMed ID: 36520530 [TBL] [Abstract][Full Text] [Related]
7. Risk factors for mortality among adults registered on the routine drug resistant tuberculosis reporting database in the Eastern Cape Province, South Africa, 2011 to 2013. Chingonzoh R; Manesen MR; Madlavu MJ; Sopiseka N; Nokwe M; Emwerem M; Musekiwa A; Kuonza LR PLoS One; 2018; 13(8):e0202469. PubMed ID: 30133504 [TBL] [Abstract][Full Text] [Related]
8. Beyond pills and tests: addressing the social determinants of tuberculosis. Wingfield T; Tovar MA; Huff D; Boccia D; Saunders MJ; Datta S; Montoya R; Ramos E; Lewis JJ; Gilman RH; Evans C Clin Med (Lond); 2016 Dec; 16(Suppl 6):s79-s91. PubMed ID: 27956446 [TBL] [Abstract][Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
10. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects. Soedarsono S; Mertaniasih NM; Kusmiati T; Permatasari A; Juliasih NN; Hadi C; Alfian IN BMC Pulm Med; 2021 Nov; 21(1):360. PubMed ID: 34758794 [TBL] [Abstract][Full Text] [Related]
11. Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis. Lukoye D; Ssengooba W; Musisi K; Kasule GW; Cobelens FG; Joloba M; Gomez GB BMC Public Health; 2015 Mar; 15():291. PubMed ID: 25880829 [TBL] [Abstract][Full Text] [Related]
12. Unraveling the Secrets Behind the Multidrug-Resistant Tuberculosis Treatment Outcome in Chronic Renal Failure Patients Requiring Hemodialysis: A Systematic Review. Hernandez GN; Seffah K; Zaman MA; Awais N; Satnarine T; Haq A; Patel D; Gutlapalli SD; Ahmed A; Khan S Cureus; 2023 Mar; 15(3):e36833. PubMed ID: 37123717 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of the Novel Anti-TB Bedaquiline against Drug-Resistant TB in Africa: A Systematic Review of the Literature. Traoré AN; Rikhotso MC; Banda NT; Mashilo MS; Ngandu JPK; Mavumengwana V; Loxton AG; Kinnear C; Potgieter N; Heysell S; Warren R Pathogens; 2022 Jun; 11(6):. PubMed ID: 35745490 [TBL] [Abstract][Full Text] [Related]
14. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review. Laurence YV; Griffiths UK; Vassall A Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501 [TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life and its association with medication adherence in active pulmonary tuberculosis- a systematic review of global literature with focus on South Africa. Kastien-Hilka T; Abulfathi A; Rosenkranz B; Bennett B; Schwenkglenks M; Sinanovic E Health Qual Life Outcomes; 2016 Mar; 14():42. PubMed ID: 26969306 [TBL] [Abstract][Full Text] [Related]
16. Cost of three models of care for drug-resistant tuberculosis patients in Nigeria. Bada FO; Okpokoro E; Blok N; Meribole E; Dutt S; Dakum P; Abimiku A; Zwerling A; Kik SV BMC Infect Dis; 2019 Jan; 19(1):41. PubMed ID: 30630429 [TBL] [Abstract][Full Text] [Related]
17. First national tuberculosis patient cost survey in Lao People's Democratic Republic: Assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV status. Chittamany P; Yamanaka T; Suthepmany S; Sorsavanh T; Siphanthong P; Sebert J; Viney K; Vixaysouk T; Nagai M; Seevisay V; Izumi K; Morishita F; Nishikiori N PLoS One; 2020; 15(11):e0241862. PubMed ID: 33180777 [TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes and antiretroviral uptake in multidrug-resistant tuberculosis and HIV co-infected patients in Sub Saharan Africa: a systematic review and meta-analysis. Chem ED; Van Hout MC; Hope V BMC Infect Dis; 2019 Aug; 19(1):723. PubMed ID: 31420021 [TBL] [Abstract][Full Text] [Related]
19. Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa. Evans D; Sineke T; Schnippel K; Berhanu R; Govathson C; Black A; Long L; Rosen S BMC Health Serv Res; 2018 Dec; 18(1):973. PubMed ID: 30558670 [TBL] [Abstract][Full Text] [Related]